News

2017

company

year

domain

Rubius Therapeutics Closes $120 Million Financing

06.21.2017

J.P Morgan Vice Chairman Stephen Berenson Joins Flagship Pioneering

Flagship Pioneering 06.14.2017

Indigo Named 2017 Technology Pioneer by the World Economic Forum

Indigo Agriculture 06.14.2017

Axcella Appoints Tony Tramontin, Ph.D., as Senior Vice President, Chief Scientific Officer

Axcella Therapeutics 06.14.2017

Seres Therapeutics Initiates SER-109 Phase 3 Study in Patients with Multiply Recurrent C. difficile Infection

Seres Therapeutics 06.12.2017

Conflict-of-Interest Rules Are Holding Back Medical Breakthroughs

Flagship Pioneering 06.09.2017

Flagship CMO Publishes Online Article in Harvard Business Review

Flagship Pioneering 06.09.2017

Potential Therapeutic Use of Exosomes Reported in NATURE

06.07.2017

Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses

Moderna 06.07.2017

Seres Therapeutics Announces Completion of Enrollment for SER-287 Phase 1b Study in Patients with Ulcerative Colitis

Seres Therapeutics 06.05.2017

Loading